tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market
Advertisement

AbCellera Biologics (ABCL) Financial Statements

Compare
2,096 Followers

AbCellera Biologics Financial Overview

AbCellera Biologics's market cap is currently $1.42B. The company's EPS TTM is $-0.12; its P/E ratio is ―; AbCellera Biologics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

AbCellera Biologics Earnings and Revenue History

AbCellera Biologics Debt to Assets

AbCellera Biologics Cash Flow

AbCellera Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis